| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.19 | 0.2 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |